BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang J, Zhou Y, Ban Y, Mi J, He Y, Li X, Liu Z, Wang K, Zhu G, Liu W, Tan Z, Sang Z. Development of naringenin-O-alkylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease. J Enzyme Inhib Med Chem 2022;37:792-816. [PMID: 35193434 DOI: 10.1080/14756366.2022.2041627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Goyal A, Verma A, Dubey N, Raghav J, Agrawal A. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease. J Food Biochem 2022;46:e14415. [PMID: 36106706 DOI: 10.1111/jfbc.14415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wu J, Zhang H, Wang Y, Yin G, Li Q, Zhuo L, Chen H, Wang Z. From tryptamine to the discovery of efficient multi-target directed ligands against cholinesterase-associated neurodegenerative disorders. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1036030] [Reference Citation Analysis]
3 Zhang H, Peng Y, Zhuo L, Wang Y, Zeng G, Wang S, Long L, Li X, Wang Z. Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy. Eur J Med Chem 2022;242:114695. [PMID: 36044812 DOI: 10.1016/j.ejmech.2022.114695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]